DKSH Holding AG Expands Precision Healthcare in Asia with Launch of LIFE-SEQ Genomic Program in Thailand

Reuters
09/15
DKSH Holding AG Expands Precision Healthcare in Asia with Launch of LIFE-SEQ Genomic Program in Thailand

DKSH Holding AG, a leading provider of market expansion services, has announced a significant expansion in the realm of genomic healthcare by partnering with PacBio and Chulalongkorn University to launch "LIFE-SEQ," Asia's first genomic program for precision health. This initiative utilizes advanced HiFi genome sequencing technology to offer lifelong care starting from newborn screening and rare disease detection. As the exclusive distributor of PacBio in Thailand, DKSH is facilitating access to this cutting-edge technology and has assembled a team of genomics experts. In its initial phase, the program will provide free sequencing for 300 newborns at Chulalongkorn University's Faculty of Medicine, with plans to expand nationwide. This expansion marks a milestone in precision healthcare, aiming to deliver genomic benefits for people of all ages across Thailand.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DKSH Holding AG published the original content used to generate this news brief on September 15, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10